Drug watch. Ophthalmic disorders.
- Published in:
- 2006
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2006 AND VI 41 AND IP 2
Results: 20
1
2
A growth hormone conversion program and patient outcomes at a not-for-profit HMO.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
3
Drug watch. Selected literature.
- Published in:
- 2006
- Publication type:
- Journal Article
4
Influence of a urinary tract infection empiric treatment pathway on physician prescribing in an academic medical center.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
5
Dalbavancin: a novel long-acting lipoglycopeptide antibiotic.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
6
FDA Drug Approvals. New formulations.
- Published in:
- 2006
- Publication type:
- Journal Article
7
Ophthalmic disorders.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 96
- Publication type:
- Article
8
Selected literature.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 96
- Publication type:
- Article
9
Medicare encourages more drug effectiveness information.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 92
- By:
- Publication type:
- Article
10
A growth hormone conversion program and patient outcomes at a not-for-profit HMO.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 82
- By:
- Publication type:
- Article
11
Influence of a urinary tract infection empiric treatment pathway on physician prescribing in an academic medical center.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 74
- By:
- Publication type:
- Article
12
Formulary considerations.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 73
- Publication type:
- Article
13
Dalbavancin A novel long-acting lipoglycopeptide antibiotic.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 59
- By:
- Publication type:
- Article
14
New formulations.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 56
- Publication type:
- Article
15
New molecular entities.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 56
- Publication type:
- Article
16
Focus on . . .
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 54
- Publication type:
- Article
17
Departments.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 54
- Publication type:
- Article
18
Experience Brief.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 54
- Publication type:
- Article
19
I Focus on . . .
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 52
- Publication type:
- Article
20
Cover Article.
- Published in:
- Formulary, 2006, v. 41, n. 2, p. 52
- Publication type:
- Article